Dr Kenneth B Kepler, MD | |
221 Piikea Ave # A, Kihei, HI 96753-8268 | |
(808) 270-0491 | |
(808) 874-6887 |
Full Name | Dr Kenneth B Kepler |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 24 Years |
Location | 221 Piikea Ave # A, Kihei, Hawaii |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649360033 | NPI | - | NPPES |
55722505 | Medicaid | HI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | MD12731 (Hawaii) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Bayada Home Health Care | Wailuku, HI | Home health agency |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kihei-wailea Medical Center. Llc | 9739070459 | 7 |
News Archive
Magnetic resonance imaging (MRI) of aortic atherosclerosis can predict the risk of heart attacks and other cardiovascular events in otherwise healthy individuals, researchers at UT Southwestern Medical Center have found.
SNM's Nanomedicine and Molecular Imaging Summit wrapped up today in Albuquerque, N.M., with in-depth discussion-and a high sense of energy looking ahead.
Vical Incorporated announced today that the company's TransVax cytomegalovirus vaccine elicited sustained increases in both cellular and antibody immune responses compared with placebo through the final 12-month follow-up in an ongoing Phase 2 trial in hematopoietic cell transplant recipients.
SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced it has extended the manufacturing capability for its Lightning-Link technology, currently marketed under the Expedeon brand, to support scalability and bulk production of antibodies.
Studying the gene-expression profiles of patients with colorectal cancer might help predict their response to chemotherapy.
› Verified 5 days ago
Entity Name | Kihei-wailea Medical Center. Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1255475752 PECOS PAC ID: 9739070459 Enrollment ID: O20040323000401 |
News Archive
Magnetic resonance imaging (MRI) of aortic atherosclerosis can predict the risk of heart attacks and other cardiovascular events in otherwise healthy individuals, researchers at UT Southwestern Medical Center have found.
SNM's Nanomedicine and Molecular Imaging Summit wrapped up today in Albuquerque, N.M., with in-depth discussion-and a high sense of energy looking ahead.
Vical Incorporated announced today that the company's TransVax cytomegalovirus vaccine elicited sustained increases in both cellular and antibody immune responses compared with placebo through the final 12-month follow-up in an ongoing Phase 2 trial in hematopoietic cell transplant recipients.
SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced it has extended the manufacturing capability for its Lightning-Link technology, currently marketed under the Expedeon brand, to support scalability and bulk production of antibodies.
Studying the gene-expression profiles of patients with colorectal cancer might help predict their response to chemotherapy.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kenneth B Kepler, MD 221 Piikea Ave # A, Kihei, HI 96753-8268 Ph: (808) 874-8100 | Dr Kenneth B Kepler, MD 221 Piikea Ave # A, Kihei, HI 96753-8268 Ph: (808) 270-0491 |
News Archive
Magnetic resonance imaging (MRI) of aortic atherosclerosis can predict the risk of heart attacks and other cardiovascular events in otherwise healthy individuals, researchers at UT Southwestern Medical Center have found.
SNM's Nanomedicine and Molecular Imaging Summit wrapped up today in Albuquerque, N.M., with in-depth discussion-and a high sense of energy looking ahead.
Vical Incorporated announced today that the company's TransVax cytomegalovirus vaccine elicited sustained increases in both cellular and antibody immune responses compared with placebo through the final 12-month follow-up in an ongoing Phase 2 trial in hematopoietic cell transplant recipients.
SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced it has extended the manufacturing capability for its Lightning-Link technology, currently marketed under the Expedeon brand, to support scalability and bulk production of antibodies.
Studying the gene-expression profiles of patients with colorectal cancer might help predict their response to chemotherapy.
› Verified 5 days ago
Melvin Daniel Burton, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 380 Huku Lii Pl, Suite 204, Kihei, HI 96753 Phone: 808-874-8774 Fax: 808-874-8947 | |
Maria Theresa David, D.O. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 3860 Wailea Alanui Drive,, Suite 102, Kihei, HI 96753 Phone: 808-875-1270 Fax: 808-875-1281 | |
Dr. Mark David Lipetz, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 41 E Lipoa Street, Suite 22, Kihei, HI 96753 Phone: 808-891-1177 Fax: 808-891-2255 | |
Dr. Peter Daniel Muthard, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 380 Huku Lii Pl, Suite 204, Kihei, HI 96753 Phone: 808-874-8774 | |
Dr. Loma Harrison Hassell Ii, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 567 Kupulau Dr, Kihei, HI 96753 Phone: 808-280-9638 Fax: 844-342-7003 |